Stocks › CLNS
CLNS
CLNS·USD
—
No end-of-day price on record
CLNS
CLNS
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CLNSS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CLNS by members of U.S. Congress · 3 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
 Greg GianforteHouse · R · MT |
CLNSCLNS · Stock |
Purchase $50,001 - $100,000 |
Apr 13, 2018 | Mar 26, 2018 | Filing ↗ |
| Greg GianforteHouse · R · MT |
CLNSCLNS · Stock |
Sale $15,001 - $50,000 |
Feb 14, 2018 | Feb 6, 2018 | Filing ↗ |
| Greg GianforteHouse · R · MT |
CLNSCLNS · Stock |
Sale $15,001 - $50,000 |
Jan 4, 2018 | Dec 15, 2017 | Filing ↗ |
Whale Activity
Institutional 13F positions
No 13F positions in CLNS among the institutional filers we track.
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CLNS insiders, by quarter · Form 4
No open-market insider buys or sells in the last two years.
Recent Insider Transactions
78 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| PARKER GEORGE GCDirector | Grant / award | +25.2K | $0.00 | $0 | May 10, 2018 | Form 4 ↗ |
| Traenkle Kevin P.Chief Investment Officer | Other | +134.9K | — | — | Apr 2, 2018 | Form 4 ↗ |
| BARRACK THOMAS JRExecutive Chairman · Director | Other | +28.1K | $0.00 | $0 | Apr 2, 2018 | Form 4 ↗ |
| BARRACK THOMAS JRExecutive Chairman · Director | Other | −28.1K | $0.00 | $0 | Apr 2, 2018 | Form 4 ↗ |
| BARRACK THOMAS JRExecutive Chairman · Director | Other | −629.4K | — | — | Apr 2, 2018 | Form 4 ↗ |
| BARRACK THOMAS JRExecutive Chairman · Director | Conversion | +629.4K | — | — | Apr 2, 2018 | Form 4 ↗ |
| Tangen Darren J.Exec. VP - CFO | Other | +91.0K | — | — | Apr 2, 2018 | Form 4 ↗ |
| Sanders Ronald M.Exec. VP - CLO & Secretary | Other | +53.1K | — | — | Apr 2, 2018 | Form 4 ↗ |
| Redington NealeChief Accounting Officer | Other | +3,379 | — | — | Apr 2, 2018 | Form 4 ↗ |
| Somers John A.Director | Purchase | +2,000 | $5.66 | $11K | Mar 23, 2018 | Form 4 ↗ |
| Redington NealeChief Accounting Officer | Grant / award | +43.7K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| SALTZMAN RICHARD BCEO & President · Director | Grant / award | +236.0K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| BARRACK THOMAS JRExecutive Chairman · Director | Grant / award | +315.3K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| Hedstrom Mark M.Chief Operating Officer | Grant / award | +97.8K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| Sanders Ronald M.Exec. VP - CLO & Secretary | Grant / award | +79.1K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| Traenkle Kevin P.Chief Investment Officer | Grant / award | +78.0K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| Tangen Darren J.Exec. VP - CFO | Grant / award | +516.9K | $0.00 | $0 | Mar 15, 2018 | Form 4 ↗ |
| Schoenherr Charles WDirector | Purchase | +5,000 | $5.93 | $30K | Mar 6, 2018 | Form 4 ↗ |
| Steffens JohnDirector | Purchase | +10.0K | $5.94 | $59K | Mar 6, 2018 | Form 4 ↗ |
| Fosheim Jon ADirector | Purchase | +4,000 | $5.99 | $24K | Mar 5, 2018 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CLNS · SEC Form N-PORT
Funds report their holdings by CUSIP, and CLNS could not be matched to one, so no fund holdings are shown.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CLNS as client
No lobbying filings found naming CLNS as the client.
Government Contracts
Federal awards to CLNS · USAspending
No federal contract awards found for CLNS.
U.S. Patents
Recent USPTO applications naming CLNS
No USPTO patent applications found for CLNS.
Annual Financials
From CLNS's 10-K filings · XBRL
No annual XBRL figures on record for CLNS. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
No price history on record for CLNS.
Material Events (8-K)
Corporate events filed with the SEC
No 8-K filings on record.
About CLNS
From SEC EDGAR company records
No company profile on record.